R. L. Proia and T. Hla, Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy, J Clin Invest, vol.125, issue.4, pp.1379-1387, 2015.

H. Obinata and T. Hla, Sphingosine 1-phosphate in coagulation and inflammation, Semin Immunopathol, vol.34, issue.1, pp.73-91, 2012.

K. Mendelson, T. Evans, and T. Hla, Sphingosine 1-phosphate signalling, Development, vol.141, issue.1, pp.5-9, 2014.

A. Olivera, K. Mizugishi, and A. Tikhonova, The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis, Immunity, vol.26, issue.3, pp.287-297, 2007.

Y. Xiong, P. Yang, R. L. Proia, and T. Hla, Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development, J Clin Invest, vol.124, issue.11, pp.4823-4828, 2014.

S. L. Gazit, B. Mariko, and P. Thérond, Platelet and erythrocyte sources of S1P are redundant for vascular development and homeostasis, but both rendered essential after plasma S1P depletion in anaphylactic shock, Circ Res, vol.119, issue.8, pp.110-126, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02442039

N. Urtz, F. Gaertner, V. Bruehl, and M. L. , Sphingosine 1-phosphate produced by sphingosine kinase 2 intrinsically controls platelet aggregation in vitro and in vivo, Circ Res, vol.117, issue.4, pp.376-387, 2015.

K. Mizugishi, T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel et al., Essential role for sphingosine kinases in neural and vascular development, Mol Cell Biol, vol.25, issue.24, pp.11113-11121, 2005.

S. C. Sensken, C. Bode, M. Nagarajan, U. Peest, O. Pabst et al., Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia, J Immunol, vol.184, issue.8, pp.4133-4142, 2010.

J. G. Cyster and S. R. Schwab, Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs, Annu Rev Immunol, vol.30, pp.69-94, 2012.

R. Pappu, S. R. Schwab, and I. Cornelissen, Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, vol.316, issue.5822, pp.295-298, 2007.

K. Venkataraman, Y. M. Lee, and J. Michaud, Vascular endothelium as a contributor of plasma sphingosine 1-phosphate, Circ Res, vol.102, issue.6, pp.669-676, 2008.

P. Hänel, P. Andréani, and M. H. Gräler, Erythrocytes store and release sphingosine 1-phosphate in blood, FASEB J, vol.21, issue.4, pp.1202-1209, 2007.

T. M. Vu, A. N. Ishizu, and J. C. Foo, Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets, Nature, vol.550, issue.7677, pp.524-528, 2017.

A. Mendoza, B. Bréart, and W. D. Ramos-perez, The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate, Cell Reports, vol.2, issue.5, pp.1104-1110, 2012.

K. Yanagida and T. Hla, Vascular and immunobiology of the circulatory sphingosine 1-phosphate gradient, Annu Rev Physiol, vol.79, issue.1, pp.67-91, 2017.

J. A. Green, K. Suzuki, and B. Cho, The sphingosine 1-phosphate receptor S1P 2 maintains the homeostasis of germinal center B cells and promotes niche confinement, Nat Immunol, vol.12, issue.7, pp.672-680, 2011.

A. Skoura, J. Michaud, and D. S. Im, Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis, Arterioscler Thromb Vasc Biol, vol.31, issue.1, pp.81-85, 2011.

M. Ishii, J. Kikuta, Y. Shimazu, M. Meier-schellersheim, and R. N. Germain, Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo, J Exp Med, vol.207, issue.13, pp.2793-2798, 2010.

L. Zhang, M. Orban, and M. Lorenz, A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis, J Exp Med, vol.209, issue.12, pp.2165-2181, 2012.

T. Hla, S. Galvani, S. Rafii, and R. Nachman, S1P and the birth of platelets, J Exp Med, vol.209, issue.12, pp.2137-2140, 2012.

L. Zhang, N. Urtz, and F. Gaertner, Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P), Blood, vol.122, issue.5, pp.791-802, 2013.

S. Golfier, S. Kondo, and T. Schulze, Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4, FASEB J, vol.24, issue.12, pp.4701-4710, 2010.

M. Bigaud, D. Guerini, A. Billich, F. Bassilana, and V. Brinkmann, Second generation S1P pathway modulators: research strategies and clinical developments, Biochim Biophys Acta, vol.1841, issue.5, pp.745-758, 2014.

S. Pyne, D. R. Adams, and N. J. Pyne, Sphingosine kinases as druggable targets, 2018.

, Handb Exp Pharmacol

S. Weske, M. Vaidya, and A. Reese, Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss, Nat Med, vol.24, issue.5, pp.667-678, 2018.

Z. Zhu, Y. Fu, and D. Tian, Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial, Circulation, vol.132, issue.12, pp.1104-1112, 2015.

Y. Fu, J. Hao, and N. Zhang, Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study, JAMA Neurol, vol.71, issue.9, pp.1092-1101, 2014.

M. L. Allende, G. Tuymetova, B. G. Lee, E. Bonifacino, Y. P. Wu et al., S1P1 receptor directs the release of immature B cells from bone marrow into blood, J Exp Med, vol.207, issue.5, pp.1113-1124, 2010.

W. D. Ramos-perez, V. Fang, D. Escalante-alcalde, M. Cammer, and S. R. Schwab, A map of the distribution of sphingosine 1-phosphate in the spleen, Nat Immunol, vol.16, issue.12, pp.1245-1252, 2015.

J. W. Choi, S. E. Gardell, and D. R. Herr, FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation, Proc Natl Acad Sci, vol.108, issue.2, pp.751-756, 2011.

M. L. Allende, M. Bektas, and B. G. Lee, Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking, J Biol Chem, vol.286, issue.9, pp.7348-7358, 2011.

E. Camerer, J. B. Regard, and I. Cornelissen, Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice, J Clin Invest, vol.119, issue.7, pp.1871-1879, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-02441617

M. Kono, A. E. Tucker, J. Tran, J. B. Bergner, E. M. Turner et al., Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo, J Clin Invest, vol.124, issue.5, pp.2076-2086, 2014.

R. Tiedt, T. Schomber, H. Hao-shen, and R. C. Skoda, Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo, Blood, vol.109, issue.4, pp.1503-1506, 2007.

A. Schmitt, A. Drouin, J. M. Massé, J. Guichard, H. Shagraoui et al., Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis, Leuk Lymphoma, vol.43, issue.4, pp.719-724, 2002.

M. Bektas, M. L. Allende, and B. G. Lee, Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver, J Biol Chem, vol.285, issue.14, pp.10880-10889, 2010.

S. Claxton, V. Kostourou, S. Jadeja, P. Chambon, K. Hodivala-dilke et al., Efficient, inducible Cre-recombinase activation in vascular endothelium, Genesis, vol.46, issue.2, pp.74-80, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00282602

S. L. Swendeman, Y. Xiong, and A. Cantalupo, An engineered S1P chaperone attenuates hypertension and ischemic injury, Sci Signal, vol.10, issue.492, p.2722, 2017.

M. G. Sanna, S. K. Wang, and P. J. Gonzalez-cabrera, Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo, Nat Chem Biol, vol.2, issue.8, pp.434-441, 2006.

M. G. Sanna, J. Liao, and J. E. , Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate, J Biol Chem, vol.279, issue.14, pp.13839-13848, 2004.

S. Massberg, P. Schaerli, and I. Knezevic-maramica, Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues, Cell, vol.131, issue.5, pp.994-1008, 2007.

C. Joseph, J. M. Quach, C. R. Walkley, S. W. Lane, L. Celso et al., Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies, Cell Stem Cell, vol.13, issue.5, pp.520-533, 2013.

Z. Sartawi, E. Schipani, K. B. Ryan, and C. Waeber, Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair, Pharmacol Res, vol.125, pp.232-245, 2017.

K. Golan, Y. Vagima, and A. Ludin, S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release, Blood, vol.119, issue.11, pp.2478-2488, 2012.

M. Ishii, J. G. Egen, and F. Klauschen, Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis, Nature, vol.465, issue.7300, pp.524-528, 2009.

E. B. Rankin, C. Wu, and R. Khatri, The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO, Cell, vol.149, issue.1, pp.63-74, 2012.

T. H. Pham, P. Baluk, and Y. Xu, Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning, J Exp Med, vol.207, issue.1, pp.17-27, 2010.

I. Pleines, S. Dütting, and D. Cherpokova, Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42, Blood, vol.122, issue.18, pp.3178-3187, 2013.

Y. Chang, F. Auradé, and F. Larbret, Proplatelet formation is regulated by the Rho/ROCK pathway, Blood, vol.109, issue.10, pp.4229-4236, 2007.

Z. Chen, O. Naveiras, and A. Balduini, The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway, Blood, vol.110, issue.1, pp.171-179, 2007.

L. Kappos, E. W. Radue, O. Connor, and P. , FREEDOMS Study Group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis, N Engl J Med, vol.362, issue.5, pp.387-401, 2010.

J. A. Cohen, F. Barkhof, and G. Comi, TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis, N Engl J Med, vol.362, issue.5, pp.402-415, 2010.

M. J. Lee, J. R. Van-brocklyn, and S. Thangada, Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1, Science, vol.279, issue.5356, pp.1552-1555, 1998.

H. Rosen, M. G. Sanna, S. M. Cahalan, and P. J. Gonzalez-cabrera, Tipping the gatekeeper: S1P regulation of endothelial barrier function, Trends Immunol, vol.28, issue.3, pp.102-107, 2007.

P. K. Mistry, J. Liu, and L. Sun, Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease, Proc Natl Acad Sci, vol.111, issue.13, pp.4934-4939, 2014.